Vitamin C Deficiency Causes Hemorrhagic Cutaneous Bullae
Vitamin C (ascorbic acid) deficiency is the vitamin deficiency that causes hemorrhagic cutaneous bullae, manifesting as part of scurvy's characteristic bleeding syndrome.
Clinical Presentation
Vitamin C deficiency presents with a progressive hemorrhagic syndrome that includes:
- Vascular purpura and hemorrhagic manifestations as primary cutaneous findings 1, 2
- Extensive ecchymoses and bleeding tendency despite normal hemostatic testing 3
- Hemorrhagic bullae can develop as part of the severe bleeding manifestations 4, 5
- Associated symptoms: weakness, myalgia, arthralgia, and later gingivorrhagia and tooth loss 1
The hemorrhagic skin changes occur because vitamin C is essential for collagen biosynthesis 6. Without adequate collagen, blood vessel integrity fails, leading to perifollicular hemorrhage, purpura, and in severe cases, hemorrhagic bullae.
Diagnostic Approach
Measure plasma vitamin C levels when you suspect scurvy based on clinical presentation:
- Deficiency confirmed by plasma ascorbic acid <2.5 mg/L (or <11.4 μmol/L) 1, 7
- "Undetectable" levels <5 μmol/L correlate with scurvy features 7
- Do not delay treatment while awaiting laboratory confirmation - start empiric therapy if clinical suspicion is high 8
Key caveat: Plasma vitamin C decreases during acute inflammation, so interpret results in context of inflammatory markers (CRP, AGP) 8. Leucocyte ascorbic acid better reflects total body stores but is not routinely available 1.
High-Risk Populations to Screen
Look for vitamin C deficiency in:
- Men living alone, elderly, homeless individuals 1
- Patients with psychiatric diseases or restrictive eating habits 3, 1
- Severely malnourished hospitalized patients (30-36% prevalence in those with severe malnutrition) 7
- Chronic alcohol consumers, smokers 8
- Patients with chronic malabsorption 8
Treatment Protocol
Administer 1 gram of vitamin C daily for 15 days 1, 2. During critical illness or acute scurvy, higher repletion doses of 2-3 grams per day IV may be given during the acute inflammatory phase 8.
Clinical improvement occurs rapidly with supplementation - expect normalization of hemoglobin and marked improvement of skin changes within weeks 3.
Important Distinction
Do not confuse with bullous hemorrhagic dermatosis from heparin 9, which presents with similar hemorrhagic bullae but occurs 5-21 days after heparin initiation in patients on anticoagulation. The key differentiator is the nutritional history and presence of other scurvy features (gingivorrhagia, perifollicular hemorrhage, poor wound healing).